Literature DB >> 32582521

Clinically node-positive micropapillary bladder cancer in a young female desiring to spare functional bladder and fertility.

Hiroshi Fukushima1, Fumitaka Koga1, Yasukazu Nakanishi1, Madoka Kataoka1, Ken-Ichi Tobisu1.   

Abstract

A 38-year-old female developing pelvic lymph node recurrence (cN2) of bladder cancer was referred to our hospital. Eighteen months earlier, she had received complete transurethral resection of bladder tumor and pathological diagnosis of muscle-invasive urothelial carcinoma with micropapillary variant had been made. She had declined radical cystectomy or chemoradiation because of a strong desire to spare the bladder and fertility. She received induction gemcitabine/cisplatin therapy. After three cycles, she achieved a clinically complete response. Then, she underwent transumbilical gasless retroperitoneoscopic super-extended pelvic lymph node dissection up to the inferior mesenteric artery trunk using the three-dimensional head-mounted display system. Pathologically, one of 42 resected lymph nodes was positive for metastasis. She is alive with no evidence of disease 5 years after lymph node dissection, retaining functional bladder and normal ovarian functions. © The Japan Society of Clinical Oncology 2020.

Entities:  

Keywords:  Fertility preservation; Lymph node excision; Minimally invasive surgical procedures; Organ preservation; Urinary bladder neoplasms

Year:  2020        PMID: 32582521      PMCID: PMC7297927          DOI: 10.1007/s13691-020-00415-5

Source DB:  PubMed          Journal:  Int Cancer Conf J        ISSN: 2192-3183


  10 in total

Review 1.  Selective bladder preservation with curative intent for muscle-invasive bladder cancer: a contemporary review.

Authors:  Fumitaka Koga; Kazunori Kihara
Journal:  Int J Urol       Date:  2012-03-12       Impact factor: 3.369

2.  New three-dimensional head-mounted display system, TMDU-S-3D system, for minimally invasive surgery application: procedures for gasless single-port radical nephrectomy.

Authors:  Kazunori Kihara; Yasuhisa Fujii; Hitoshi Masuda; Kazutaka Saito; Fumitaka Koga; Yoh Matsuoka; Noboru Numao; Kazuyuki Kojima
Journal:  Int J Urol       Date:  2012-05-15       Impact factor: 3.369

3.  The magnitude of gonadotoxicity of chemotherapy drugs on ovarian follicles and granulosa cells varies depending upon the category of the drugs and the type of granulosa cells.

Authors:  Aytac Yuksel; Gamze Bildik; Filiz Senbabaoglu; Nazli Akin; Macit Arvas; Fehmi Unal; Yagmur Kilic; Isil Karanfil; Baldan Eryılmaz; Pelin Yilmaz; Can Ozkanbaş; Cagatay Taskiran; Senai Aksoy; Yılmaz Guzel; Basak Balaban; Umit Ince; Akira Iwase; Bulent Urman; Ozgur Oktem
Journal:  Hum Reprod       Date:  2015-10-13       Impact factor: 6.918

4.  Micropapillary Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-analysis of Disease Characteristics and Treatment Outcomes.

Authors:  Mohammad Abufaraj; Beat Foerster; Eva Schernhammer; Marco Moschini; Shoji Kimura; Melanie R Hassler; Mark A Preston; Pierre I Karakiewicz; Mesut Remzi; Shahrokh F Shariat
Journal:  Eur Urol       Date:  2018-12-13       Impact factor: 20.096

5.  Fertility and gonadal function after adjuvant therapy in women diagnosed with a malignant ovarian germ cell tumor (MOGCT) during the "cisplatin era".

Authors:  O Solheim; C G Tropé; E Rokkones; J Kærn; T Paulsen; H B Salvesen; B Hagen; A B Vereide; S D Fosså
Journal:  Gynecol Oncol       Date:  2014-12-12       Impact factor: 5.482

Review 6.  Ovarian tissue cryopreservation and transplantation: a review.

Authors:  Jacques Donnez; Belen Martinez-Madrid; Pascale Jadoul; Anne Van Langendonckt; Dominique Demylle; Marie-Madeleine Dolmans
Journal:  Hum Reprod Update       Date:  2006-07-18       Impact factor: 15.610

Review 7.  How do chemotherapeutic agents damage the ovary?

Authors:  S Morgan; R A Anderson; C Gourley; W H Wallace; N Spears
Journal:  Hum Reprod Update       Date:  2012-05-30       Impact factor: 15.610

Review 8.  Micropapillary bladder cancer: current treatment patterns and review of the literature.

Authors:  Daniel L Willis; Thomas W Flaig; Donna E Hansel; Matthew I Milowsky; Robert L Grubb; Hikmat A Al-Ahmadie; Elizabeth R Plimack; Theresa M Koppie; David J McConkey; Colin P Dinney; Vanessa A Hoffman; Michael J Droller; Edward Messing; Ashish M Kamat
Journal:  Urol Oncol       Date:  2014-06-13       Impact factor: 3.498

9.  Comparative Effectiveness of Treatment Strategies for Bladder Cancer With Clinical Evidence of Regional Lymph Node Involvement.

Authors:  Matthew D Galsky; Kristian Stensland; John P Sfakianos; Reza Mehrazin; Michael Diefenbach; Nihal Mohamed; Che-Kai Tsao; Paolo Boffetta; Peter Wiklund; William K Oh; Madhu Mazumdar; Bart Ferket
Journal:  J Clin Oncol       Date:  2016-06-06       Impact factor: 44.544

10.  Clinical Outcomes of Patients With Histologic Variants of Urothelial Carcinoma Treated With Selective Tetramodal Bladder-preservation Therapy Incorporating Consolidative Partial Cystectomy.

Authors:  Toshiki Kijima; Hajime Tanaka; Sho Uehara; Soichiro Yoshida; Minato Yokoyama; Junichiro Ishioka; Yoh Matsuoka; Kazutaka Saito; Kazunori Kihara; Yasuhisa Fujii
Journal:  Clin Genitourin Cancer       Date:  2019-12-04       Impact factor: 2.872

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.